Eli Lilly and Company (LLY)
NYSE: LLY · Real-Time Price · USD
742.35
+16.63 (2.29%)
At close: Jan 21, 2025, 4:00 PM
740.00
-2.35 (-0.32%)
After-hours: Jan 21, 2025, 7:55 PM EST
Eli Lilly Employees
Eli Lilly and Company had 43,000 employees as of December 31, 2023. The number of employees increased by 4,000 or 10.26% compared to the previous year.
Employees
43,000
Change (1Y)
4,000
Growth (1Y)
10.26%
Revenue / Employee
$950,309
Profits / Employee
$194,649
Market Cap
668.44B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 43,000 | 4,000 | 10.26% |
Dec 31, 2022 | 39,000 | 4,000 | 11.43% |
Dec 31, 2021 | 35,000 | 0 | - |
Dec 31, 2020 | 35,000 | 1,375 | 4.09% |
Dec 31, 2019 | 33,625 | -5,055 | -13.07% |
Dec 31, 2018 | 38,680 | -1,975 | -4.86% |
Dec 31, 2017 | 40,655 | -1,320 | -3.14% |
Dec 31, 2016 | 41,975 | 700 | 1.70% |
Dec 31, 2015 | 41,275 | 2,140 | 5.47% |
Dec 31, 2014 | 39,135 | 1,210 | 3.19% |
Dec 31, 2013 | 37,925 | -425 | -1.11% |
Dec 31, 2012 | 38,350 | 270 | 0.71% |
Dec 31, 2011 | 38,080 | -270 | -0.70% |
Dec 31, 2010 | 38,350 | -2,010 | -4.98% |
Dec 31, 2009 | 40,360 | -140 | -0.35% |
Dec 31, 2008 | 40,500 | -100 | -0.25% |
Dec 31, 2007 | 40,600 | -900 | -2.17% |
Dec 31, 2006 | 41,500 | -1,100 | -2.58% |
Dec 31, 2005 | 42,600 | -1,900 | -4.27% |
Dec 31, 2004 | 44,500 | -1,600 | -3.47% |
Dec 31, 2003 | 46,100 | 2,400 | 5.49% |
Dec 31, 2002 | 43,700 | 2,600 | 6.33% |
Dec 31, 2001 | 41,100 | 5,400 | 15.13% |
Dec 31, 2000 | 35,700 | 4,400 | 14.06% |
Dec 31, 1999 | 31,300 | 1,500 | 5.03% |
Dec 31, 1998 | 29,800 | -1,300 | -4.18% |
Dec 31, 1997 | 31,100 | 1,900 | 6.51% |
Dec 31, 1996 | 29,200 | 2,400 | 8.96% |
Dec 31, 1995 | 26,800 | 1,900 | 7.63% |
Dec 31, 1994 | 24,900 | -7,800 | -23.85% |
Dec 31, 1993 | 32,700 | 500 | 1.55% |
Dec 31, 1992 | 32,200 | 1,400 | 4.55% |
Dec 31, 1991 | 30,800 | 1,300 | 4.41% |
Dec 31, 1990 | 29,500 | 1,700 | 6.12% |
Dec 31, 1989 | 27,800 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
LLY News
- 12 hours ago - Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last? - CNBC
- 15 hours ago - Stock Of The Day: Lilly's Strong Support Level Signals Potential Rebound - Benzinga
- 18 hours ago - Novo, Lilly Weight-Loss Drugs Reduce Risk of Alzheimer's, Study Shows. What It Means for the Stocks. - Barrons
- 21 hours ago - Eli Lilly: Market Overreacted - Seeking Alpha
- 4 days ago - Ozempic, Wegovy among drugs subject to Medicare price controls - Fox Business
- 6 days ago - US FDA approves expanded use of Lilly's bowel disease drug - Reuters
- 6 days ago - FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease - PRNewsWire
- 6 days ago - Eli Lilly: Big 2025 Ahead, But Execution Risks Exist - Seeking Alpha